Literature DB >> 26713660

[Not Available].

Thomas Werfel1, Werner Aberer2, Frank Ahrens3, Matthias Augustin4, Tilo Biedermann5, Thomas Diepgen6, Regina Fölster-Holst7, Uwe Gieler8, Annice Heratizadeh9, Julia Kahle10, Alexander Kapp11, Alexander Nast12, Katja Nemat13, Hagen Ott14, Bernhard Przybilla15, Martin Roecken1, Martin Schlaeger16, Peter Schmid-Grendelmeier17, Jochen Schmitt18, Thomas Schwennesen19, Doris Staab20, Margitta Worm21.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 26713660     DOI: 10.1111/ddg.12884

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  7 in total

1.  [Local antibiotics or antiseptics in combination with glucocorticoids].

Authors:  S Melhorn
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

2.  [Quality of patient information leaflets on atopic eczema : An analysis using the DISCERN instrument].

Authors:  J Wahl; C Apfelbacher
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

3.  [Health care of chronic inflammatory skin diseases : Do affected individuals seek dermatological care?]

Authors:  M C Schielein; L Tizek; F Seifert; T Biedermann; A Zink
Journal:  Hautarzt       Date:  2019-11       Impact factor: 0.751

Review 4.  [New aspects in systemic treatment of atopic dermatitis].

Authors:  T Werfel; A Wollenberg; T Pumnea; A Heratizadeh
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

Review 5.  Derailed Ceramide Metabolism in Atopic Dermatitis (AD): A Causal Starting Point for a Personalized (Basic) Therapy.

Authors:  Markus Blaess; Hans-Peter Deigner
Journal:  Int J Mol Sci       Date:  2019-08-15       Impact factor: 5.923

Review 6.  [Vaccinations in dermatology].

Authors:  M Sticherling
Journal:  Hautarzt       Date:  2021-01-21       Impact factor: 0.751

Review 7.  [Allergen immunotherapy for atopic dermatitis].

Authors:  Stephan Traidl; Thomas Werfel
Journal:  Hautarzt       Date:  2021-11-18       Impact factor: 0.751

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.